%0 Journal Article
%T 女性性功能障碍的研究进展<br>Research Progress of Female Sexual Dysfunction
%A 石曼曼
%A 张波
%J Advances in Clinical Medicine
%P 1194-1201
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/ACM.2024.141173
%X 女性性功能障碍(Female Sexual Dysfunction, FSD)是指女性在性反应周期(sexual response cycle)中的一个或几个环节发生障碍，以致不能产生满意的性交所必需的性生理反应和性快感，是现代社会比较普遍的疾病之一，国外的流行病学调查发现，女性性功能障碍发病率约为20%~50%，约33%女性存在性欲减退。其中，国外报道的女性性功能障碍的发病率为40%，我国调查显示39.7%的女性有性高潮困难。患者持续地或反复地存在性欲减退的症状至少6个月，若不及时治疗，可导致患者性生活满意度下降，严重影响患者生活质量。若不及时治疗，可能会伴有生活困扰、人际交往苦恼等。基于此，本文旨在对当前女性性功能障碍的分类、病因、治疗与干预措施等进行综述。<br />
Female sexual dysfunction (FSD) is one of the common diseases in modern society, which means that women have obstacles in one or several links of the sexual response cycle, so that they can not produce the sexual physiological reaction and sexual pleasure necessary for satisfactory sexual in-tercourse. Foreign epidemiological surveys have found that the incidence of female sexual dysfunc-tion is about 20%~50%, and about 33% of women have decreased sexual desire. Among them, the incidence rate of female sexual dysfunction reported abroad is 40%, and the survey in China shows that 39.7% of women have difficulty in orgasm. The patient experiences persistent or recurrent symptoms of decreased libido for at least 6 months. If left untreated, it can lead to a decrease in sexual satisfaction and seriously affect the patient’s quality of life. If not treated in a timely manner, it may be accompanied by difficulties in daily life and interpersonal communication. Based on this, this article aims to review the classification, etiology, treatment, and intervention measures of cur-rent female sexual dysfunction.
%K 女性性功能障碍，药物治疗，成因与干预<br>Female Sexual Dysfunction
%K Medication
%K Cause and Intervention
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=79739